AI assistant
Sending…
GALECTIN THERAPEUTICS INC — Director's Dealing 2010
Jan 5, 2010
33422_dirs_2010-01-05_e9e55bf1-44f1-4979-ae79-dc9ac056ec3b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PRO PHARMACEUTICALS INC (PWRP.OB)
CIK: 0001133416
Period of Report: 2009-12-22
Reporting Person: AMELIO GILBERT F (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2009-12-22 | Common Stock | L | 7500 | $0.339 | Acquired | 507500 | Direct |
More from GALECTIN THERAPEUTICS INC
Earnings Release
2026
May 15
Interim / Quarterly Report
2026
May 15
Capital/Financing Update
2026
Mar 31
Earnings Release
2026
Mar 31
Annual Report
2026
Mar 31
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Board/Management Information
2026
Mar 17
Director's Dealing
2026
Feb 9
Board/Management Information
2026
Jan 21